Novartis Seeks EU Accelerated Review For CAR-T Therapy

T-cells attacking cancer_1200x675
Novartis is seeking EU approval for its CAR-T cell therapy
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Europe

More from Geography